Karyopharm Therapeutics
KPTI
KPTI
81 hedge funds and large institutions have $701M invested in Karyopharm Therapeutics in 2014 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less call options, than puts
Call options by funds: $1.34M | Put options by funds: $1.65M
Holders
81
Holding in Top 10
2
Calls
$1.34M
Puts
$1.65M
Top Buyers
| 1 | +$31.7M | |
| 2 | +$16.6M | |
| 3 | +$8.71M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$4.02M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$3.9M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$4.37M | |
| 3 | -$4.18M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.65M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.48M |